Clinical Trials Browser

Has announcements × Neuroendocrine Tumors × lutetium Lu 177 dotatate × Clear all

NCT01578239 2022-04-04

NETTER-1

Phase 3 Completed

231 enrolled 16 charts 2 FDA

Neuroendocrine Tumors